Why Is LNTH Stock Up After Hours?

robot
Abstract generation in progress

(MENAFN- AsiaNet News)

Shares of Lantheus Holdings, Inc. (LNTH) rose 5% after hours on Friday after the company announced that the U.S. Food and Drug Administration has approved its PYLARIFY TruVu injection.

The injection is indicated for imaging certain lesions in men with prostate cancer.

It is now expected to be commercially available in the fourth quarter of 2026.

Get updates to this developing story directly on Stocktwits.

MENAFN06032026007385015968ID1110829384

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin